Please login to the form below

Not currently logged in
Email:
Password:

LHON

This page shows the latest LHON news and features for those working in and with pharma, biotech and healthcare.

Encouraging data for GenSight’s blinding retinal disease gene therapy

Encouraging data for GenSight’s blinding retinal disease gene therapy

Better results after April's setback. Gensight has revealed some promising data for its gene therapy GS010, which is currently in testing to treat those with Leber hereditary optic neuropathy (LHON), ... If approved, the gene therapy would compete with

Latest news

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Medscape Education Global

Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide....

Latest intelligence

William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...
Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...